MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

csiro: polynovo cost benefit analysis, page-13

  1. 17,899 Posts.
    lightbulb Created with Sketch. 1657
    really?..I'm sure the early holders of FMG, PDN and a host of others wouldn't agree
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.